Innovative Bayesian statistics for enhanced decision making for pharmaceutical drug development

用于增强药物开发决策的创新贝叶斯统计

• 批准号: LP0991062
• 负责人: Prof Anthony Pettitt
• 金额: $ 24.32万
• 依托单位: Queensland University of Technology
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-06-30 至 2015-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0991062
• 关键词: Innovative; Bayesian; statistics; enhanced; decision

This project addresses Australia's national research priority of Promoting and Maintaining Good Health, and will lead to improvements in health outcomes by patients accessing new drugs sooner, enhancing research, and reducing the cost of health care. Decision making in early stages of drug development will be improved by using novel statistical methods, which could also be applied in a variety of situations involving decision making procedures. This will be achieved through cross-disciplinary and university-industry collaboration, utilising Australian and international expertise. National demands for quality science and trained researchers underpinning health decisions will be contributed to.

该项目涉及澳大利亚促进和保持良好健康的国家研究优先事项，并将通过患者更快地获得新药、加强研究和降低医疗保健成本来改善健康结果。药物开发早期阶段的决策将通过使用新的统计方法得到改善，这些方法也可以应用于涉及决策程序的各种情况。这将通过跨学科和大学与行业的合作，利用澳大利亚和国际专业知识来实现。将促进国家对高质量科学和训练有素的研究人员的需求，以支持卫生决策。